Beena Shah
Neurology · Hollywood, MDNPI 1447279203
Payments from drug & device makers
Across 152 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$429
- Teva Pharmaceuticals USA, Inc.$413
- Merck$308
- UCB, Inc.$269
- Lilly USA, LLC$191
- Amgen$155
- plus $901 from 27 others
What the payments were for
- Food & beverage$2,57997%
- Education$873%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $429 |
| Teva Pharmaceuticals USA, Inc. | 21 | $413 |
| Merck | 15 | $308 |
| UCB, Inc. | 15 | $269 |
| Lilly USA, LLC | 12 | $191 |
| Amgen | 8 | $155 |
| E.r. Squibb & Sons, L.L.C. | 5 | $95 |
| Lundbeck LLC | 6 | $94 |
| Novartis | 5 | $92 |
| Mallinckrodt Enterprises LLC | 4 | $69 |
| Pfizer | 3 | $48 |
| AstraZeneca | 3 | $43 |
| EMD Serono, Inc. | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Mallinckrodt Hospital Products Inc. | 2 | $37 |
| Johnson & Johnson | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Biohaven Pharmaceuticals, Inc. | 2 | $27 |
| Philips North America LLC | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Electromed, Inc. | 1 | $18 |
| MDD US Operations, LLC | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Biogen | 1 | $16 |
| Avion Pharmaceuticals | 1 | $16 |
| SK Life Science, Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Atricure, Inc. | 1 | $15 |
| GSK | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
| Livanova USA, Inc. | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $11 |
How this compares
$2,667 in reported general payments places this provider in the 50th percentile of 442 neurology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 11 | $7,624 |
| Gabapentin | 324 | $6,087 |
| Levetiracetam | 140 | $5,405 |
| Memantine Hcl | 128 | $5,381 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 127 | $3,130 |
| Donepezil Hcl | 235 | $2,902 |
| Memantine Hcl ErMemantine Hcl | 11 | $2,354 |
| Lacosamide | 20 | $2,111 |
| Duloxetine Hcl | 53 | $1,846 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 41 | $1,761 |
| Propranolol Hcl ErPropranolol Hcl | 40 | $1,730 |
| Pregabalin | 48 | $1,101 |
| Ropinirole Hcl | 60 | $1,091 |
| Topiramate | 64 | $822 |
| Primidone | 28 | $811 |
Paid to pharmacies, not to this prescriber.
Other neurology in Hollywood
- Jose MasdeuBethesda$5.8M
- Ellen MowryBaltimore$5.7M
- Daniel BeckerLutherville$4.2M
- Michael PolydefkisBaltimore$4.1M
- Pavel KleinBethesda$3.2M
- Jeffrey RothsteinBaltimore$3M
- Pavan BhargavaBaltimore$2.8M
- Thomas CrawfordBaltimore$2.4M
- Nicholas MaragakisBaltimore$2.2M
- Shiv SaidhaBaltimore$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.